$250 million, 300 scientists and 40 labs: Sean Parker’s revolutionary project to ‘solve’ cancer
By Ariana Eunjung Cha – The Washington Post. Millionaire Sean Parker, famous for his founding roles at…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Protective mastectomies that preserve nipple safe for women at high breast cancer risk
Protective mastectomies that preserve the nipple and surrounding skin prevent breast cancer as effectively as…
AACR 2016: New RAF-targeted therapeutic shows early promise against tumours with BRAF and RAS mutations
The new investigational anticancer therapeutic BGB-283, which targets the RAF family of proteins, was safe,…
AACR 2016: SPF30 sunscreens delay melanoma incidence in preclinical model
Application of sun protection factor 30 (SPF30) sunscreen prior to exposure to ultraviolet-B (UVB) light…
Low-carb, high-fat diet slows growth of aggressive brain tumour in mouse models
University of Florida Health researchers have slowed a notoriously aggressive type of brain tumour in…
Modified flu virus can ‘resensitize’ resistant pancreatic cancer cells to chemotherapy
A common flu virus could be used to overcome patients’ resistance to certain cancer drugs…
AACR 2016: Five-year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates
More than a third of metastatic melanoma patients (34 percent) who received the anti-PD-1 immunotherapeutic…
Gene editing could stop cancer cells escaping the immune system
Cutting off a sleep-switch on immune cells inside a tumour wakes up the cells and…
Many survivors of childhood brain cancer have cognitive difficulties, but these can be treated
Kimberley Docking, University of Sydney. The case of six year old Oshin Kiszko who was…
AACR 2016: Delays in radiation therapy increase chance of breast tumour development in women treated for ductal carcinoma in situ
Women who underwent treatment for ductal carcinoma in situ (DCIS), a noninvasive breast abnormality, were…